LCN2 and metabolic dysfunction-associated steatotic liver disease: To explore the potential role of hepatic LCN2 in the development of PCB-induced NAFLD/NASH, we examined the effect of the in vitro knockdown of hepatic LCN2 using a siRNA delivery system.